(Q36703033)

15 August 2017

1 reference

title

The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? (English)

1 reference

15 August 2017

1 reference

1 reference

Kenneth L Jones

1

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

311-321

1 reference

The metabolic syndrome: requiescat in pace

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

A multidisciplinary approach to the adolescent bariatric surgical patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Bariatric surgery for severely overweight adolescents: concerns and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Behavioral treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Pharmacological and surgical treatments for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Familial hypercholesterolemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Effects of the amount and intensity of exercise on plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

Biological variations in hyperlipidemic children and adolescents treated with fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2006.00212.X

10.1111/J.1399-5448.2006.00212.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference